Stuart Spencer
Impact in
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment
- Oncology top 1%
- PARP inhibition in cancer therapy
Papers in
- Co-authors
- Anitra Fielding (14 shared papers)Jonathan A. Ledermann (11 shared papers)Charlie Gourley (12 shared papers)Darren Hodgson (6 shared papers)Michael Friedländer (11 shared papers)Gordon Rustin (11 shared papers)Ursula A. Matulonis (11 shared papers)Ronnie Shapira‐Frommer (9 shared papers)
- Journals
- Journal of Clinical Oncology (9 papers)The Lancet (7 papers)Annals of Oncology (4 papers)British Journal of Cancer (4 papers)The Lancet Oncology (3 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Stuart Spencer
50 papers receiving 2.3k citations
Stuart Spencer's Hit Papers
Peers
Comparison fields: 5 of 109
- Reproductive Medicine 690
- Oncology 1.6k
- Genetics 471
- Cancer Research 192
- Otorhinolaryngology 43
Countries citing papers authored by Stuart Spencer
This map shows the geographic impact of Stuart Spencer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart Spencer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart Spencer more than expected).
Fields of papers citing papers by Stuart Spencer
This network shows the impact of papers produced by Stuart Spencer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart Spencer. The network helps show where Stuart Spencer may publish in the future.
Co-authors
The 25 scholars most cited alongside Stuart Spencer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial Hit paper breakdown → | 2014 | 1102 |
| 2 | 2016 | 324 | |
| 3 | 2018 | 173 | |
| 4 | 2013 | 134 | |
| 5 | 2016 | 74 | |
| 6 | 2017 | 68 | |
| 7 | 2016 | 45 | |
| 8 | 2007 | 34 | |
| 9 | 2022 | 28 | |
| 10 | 2014 | 25 | |
| 11 | 2006 | 24 | |
| 12 | 2013 | 23 | |
| 13 | 2013 | 22 | |
| 14 | 2006 | 19 | |
| 15 | 2015 | 18 | |
| 16 | 2020 | 17 | |
| 17 | 2014 | 14 | |
| 18 | 2014 | 14 | |
| 19 | 2010 | 12 | |
| 20 | 2013 | 11 |
About Stuart Spencer
Stuart Spencer is a scholar working on Oncology, Genetics, Reproductive Medicine, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 52 papers that have together received 2.3k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (17 papers), Ovarian cancer diagnosis and treatment (8 papers), BRCA gene mutations in cancer (7 papers), Lung Cancer Research Studies (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Head and Neck Cancer Studies (3 papers), Animal Genetics and Reproduction (3 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). The work is most often cited by research in Reproductive Medicine (690 citations), Oncology (1.6k citations), Genetics (471 citations), Cancer Research (192 citations) and Otorhinolaryngology (43 citations). Stuart Spencer has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Anitra Fielding, Jonathan A. Ledermann, Charlie Gourley, Darren Hodgson, Michael Friedländer, Gordon Rustin, Ursula A. Matulonis, Ronnie Shapira‐Frommer, Tamar Safra and Werner Meier. Their work appears in journals such as Journal of Clinical Oncology, The Lancet, Annals of Oncology, British Journal of Cancer and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.